DRI Cocaine Metabolite Assay
K-Number: K181499 · 2018-07-06
Device Summary
Frequently Asked Questions
What is the DRI Cocaine Metabolite Assay?
DRI Cocaine Metabolite Assay is a medical device that received FDA 510(k) clearance on 2018-07-06. The listed applicant is Microgenics Corporation. The 510(k) number is K181499.
When did DRI Cocaine Metabolite Assay receive FDA 510(k) clearance?
DRI Cocaine Metabolite Assay received FDA 510(k) clearance on 2018-07-06, under 510(k) number K181499.
Who is the listed applicant for DRI Cocaine Metabolite Assay?
The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for DRI Cocaine Metabolite Assay?
The FDA product code for DRI Cocaine Metabolite Assay is DIO.
Other records listing Microgenics Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DIO)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.